| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071221 Heterocyclic oxime compounds |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071178 Bone disorders; osteoporosis |
| 07/04/2006 | US7071170 Bactericides; antiprotozoa agents |
| 07/04/2006 | US7071169 Pyrane derivatives as both ACE-and NEP-inhibitors |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070793 Antigen protein and nucleic acid coding for said protein |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2264721C A1 adenosine receptor antagonists |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 06/29/2006 | WO2006068822A1 Notch receptor agonists and uses |
| 06/29/2006 | WO2006068117A1 Preventive for nephropathy and food having the function imparted thereto |
| 06/29/2006 | WO2006067823A2 Pharmaceutical composition comprising nifedipine and mesalazine for the treatment of rectoanal tenesmus |
| 06/29/2006 | US20060142374 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142289 Method of treating migraine headaches |
| 06/29/2006 | US20060142268 1,4,5,6-tetrahydroimidazo[4,5-d]benzazepine derivative or salt thereof |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142243 Promoting repair of skin and mucous membrane tissues, the product of the present invention exhibits unique effects for controlling inflammation, damage, infection, and exudation; side effect reduction; topical administration |
| 06/29/2006 | US20060142229 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/29/2006 | US20060142222 Novel gene relating to fibrotic conditions |
| 06/29/2006 | US20060142201 amino acid sequence containing Xaa1 Xaa2 Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys SEQ ID NO. 3 where Xaa1 is a N-terminal pyroglutamate (pGlu) or D-pyroglutamate (DpGlu) residue; and Xaa2 is Asn or a deletion; prophylaxis; neuropathic pain, inflammation, incontinence, cardiovascular conditions |
| 06/29/2006 | US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060140945 Nephropathy-associated gene |
| 06/29/2006 | DE102004061288A1 New 3-amino-pyrazolo(3,4b)pyridine derivatives are protein tyrosine kinases inhibitors useful e.g. for treating hyperproliferation of body cells, neurodegenerative disease, blood vessel disease and angiogenic disease |
| 06/28/2006 | EP1674454A1 SUBSTITUTED 2-AMINO- 1,2,4 TRIAZOLO 1,5-a PYRIMIDINE DERIVATIVE AND USE THEREOF |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674109A1 Remedy for kidney diseases |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673096A1 Use of a vitamin d3 analogue for the treatment of benign prostatic hyperplasia |
| 06/28/2006 | EP1379258B1 Low salt forms of polyallylamine |
| 06/28/2006 | EP1259243B1 Bupropion metabolites and methods of their synthesis and use |
| 06/28/2006 | CN1795176A Azabicyclo derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1795007A Methods and compositions for the treatment of gastrointestinal disorders |
| 06/28/2006 | CN1794985A Azabicyclo derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1794984A Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1794978A Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 06/28/2006 | CN1792365A Prescription of traditional Chinese medicine for dissolving calculus in vivo |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/28/2006 | CN1261154C Chinese medicine capsule for treating infection of urinary system and its preparing method |
| 06/28/2006 | CN1261144C Medicinal composition for treating lithiasis and its preparation method |
| 06/28/2006 | CN1261142C Use of a serra repens extract for the production of a medicament to treat prostate cancer |
| 06/28/2006 | CN1261114C Chinese traditional medicine composition for chronic nephritis, its preparation method and quality control method |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067554 Method for the synthesis of compounds of formula I and their uses thereof |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067546 high yield, industrial scale crystallization of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (Candesartan) from solution or suspension with an aprotic polar solvent, between zero and 30 degrees Celsius |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067537 Anticancer, antitumor agents |
| 06/27/2006 | US7067535 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067520 Antidiabetic agents; hypoglycemic agents; antilipemic agents; dietetics |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067133 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/22/2006 | WO2006064945A1 Process for producing muscarine receptor antagonist and intermediate therefor |
| 06/22/2006 | WO2006064351A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | WO2006064336A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | WO2006034832A3 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/22/2006 | WO2006018743A3 Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135812 Thiol-based NAALADase inhibitors |
| 06/22/2006 | US20060135613 Carboxamides derivatives |
| 06/22/2006 | US20060135611 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/22/2006 | US20060135597 Administering a bithiophene substituted by a carboxyalkyl group and a pyridinyl or pyrimidinyl group to treat irritable bowel syndrome, chronic heart failure, angina, cardiac infarction, cerebral infarction, pollakiuria, urinary incontinence, or, cerebral ischemia |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135583 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
| 06/22/2006 | US20060135521 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 06/22/2006 | US20060135520 Method of treating peripheral neuropathy |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135505 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060134303 Adding fatty acid ester, a fatty acid amide, a free fatty acid or a hydrocarbon, to a mixture of a fat or an oil, being edible or for use in cosmetics; stripping and separating the environmental pollutant present in the fat or oil |
| 06/22/2006 | US20060134075 Composition and method for improving function of embryonic kidney transplants |
| 06/22/2006 | CA2591415A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | CA2590229A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/21/2006 | EP1672062A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671961A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1506193B1 Carbamate-substituted pyrazolopyridines |
| 06/21/2006 | EP1463797A4 Methods of kidney transplantation utilizing developing nephric tissue |
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |